As a company that specializes in drug information, DrugBank always tries to remain informed about novel treatments, drug approvals, and drugs that are impacting global health. At the top of our minds lately is Zolgensma (Onasemnogene abeparvovec), a gene therapy indicated for the treatment of Spinal Muscular Atrophy. So why
